Survey reveals most people unaware that hepatitis B and C are risk factors for liver disease

July 28, 2026

On this World Hepatitis Day, (July 28th) Liver UK has revealed that over three quarters of the UK public are not aware that hepatitis B and C are risk factors for liver disease. 

In the survey commissioned by the charity (previously known as the British Liver Trust and Children’s Liver Disease Foundation) only 23% of respondents knew that both hepatitis B and C can lead to liver damage. 

Hepatitis B is a common virus affecting millions of people around the world, and while most adults will be able to fight off acute hepatitis B within months, living with chronic hep B increases the risk of serious liver damage and liver cancer. Because chronic hep B is usually picked up at birth, people infected may have no idea they have it until they develop serious liver disease in adulthood.  An effective vaccine is now given to all babies born in the UK and is also available for free to anyone at risk. 

 Whilst there is no vaccine for hepatitis C, effective treatment is available. Most people infected will not have symptoms for years or even decades but if left untreated, the virus can lead to cirrhosis and liver cancer. 

“The real danger with both Hep B and C is that people affected could have mild or no symptoms for years while the virus is doing serious damage to their liver,” said Pam Healy, Chief Executive of Liver UK. “The lack of public awareness about this is concerning to us because if timely action is taken, serious liver disease can be prevented. It’s vital that anyone who thinks they might be infected or at risk seeks medical advice as early as possible.”    

Information about the risk factors, symptoms and treatment for both hepatitis B and hepatitis C is available from Liver UK. 

More news

Our Budget Case to the Treasury: Investing in Prevention

Our Budget Case to the Treasury: Investing in Prevention

The Autumn Budget on 28th October is a chance to prevent thousands of families from experiencing the devastating impact of liver disease. Because 90% of liver disease is preventable, government action on alcohol harm and obesity could ...
Liver UK helps shape new European recommendations on liver cancer surveillance

Liver UK helps shape new European recommendations on liver cancer surveillance

A major new paper published in The Lancet Regional Health – Europe has highlighted the challenges of detecting liver cancer earlier across Europe and sets out practical lessons from countries around the world to improve surveillance ...
The LIVERAGE research studies

The LIVERAGE research studies

The LIVERAGE and LIVERAGE Cirrhosis studies are large clinical research studies for adults living with MASLD, a type of fatty liver disease. These studies focus on people with MASH, a more advanced form of MASLD.  The studies include ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.